Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is overpriced but is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
Lupin Limited is engaged in producing, developing and marketing a range of branded and generic formulations, biotechnology products and active pharmaceutical ingredients (APIs) across the world.
Customise key metrics, see detailed forecasts, download stock data and more
Pledged promoter holdings is insignificant
In last 3 months, mutual fund holding of the company has almost stayed constant
1 month ago•Business Today
1 month ago•Economic Times
1 month ago•The Hindu Businessline
Lupin Limited has informed the Exchange about signing of Share Subscription & Shareholder's Agreement with Sunsure Solarpark Seventeen Private Limited and Sunsure Energy Private Limited to make equity investment in Sunsure Solarpark Seventeen Private Limited in the capacity as a Captive User. | Download
Lupin Limited has informed the Exchange about signing of Share Subscription & Shareholder's Agreement with Sunsure Solarpark Seventeen Private Limited and Sunsure Energy Private Limited to make equity investment in Sunsure Solarpark Seventeen Private Limited in the capacity as a Captive User. | Download
Final • Div/Share: ₹ 8
Total Promoter HoldingIncreasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant